Dare Bioscience (DARE) Reports In-Line Q2 EPS
Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.
Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.